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Available online 23 October 2015Human dermal ﬁbroblasts from a Nijmegen Breakage Syndrome (NBS) patient bearing the 657del5 mutation
within the DNA repair gene NIBRIN were used to generate two iPSC-lines (vNBS8-iPS-c1, vNBS8-iPS-c2) by ret-
roviral transduction of OCT4, SOX2, c-MYC and KLF4. Pluripotency was conﬁrmed both in vivo and in vitro.
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Chromosomal analysis revealed a karyotype with few aberrations. In
addition microarray-based transcriptome analysis conﬁrmed similarity
of the derived NBS-iPS-clones to a collection of validated hESCs and
iPSCs derived transcriptomes (Müller et al., 2011, http://www.
pluritest.org).3. Materials and methods
3.1. Ethics statement
The NBS patient dermal ﬁbroblast cells were provided by Prof. Dr.
Karl Sperling (Institute for Medical Genetics, Charité) with approval by
the Ethics Commission of the Charité—Universitätsmedizin Berlin.3.2. Cell culture
Neonatal foreskin ﬁbroblasts, HFF1 and BJ were purchased from
ATCC (#SCRC-1041 and #CRL-2522, respectively). Fibroblasts from pa-
tients with NBS were provided by Prof. Karl Sperling, Charité Berlin.
All cells used were cultured at 37 °C, 5% CO2 and either 21% (standard)
or 5% oxygen in an incubator under humidiﬁed atmosphere. Somatic
cells were usually cultured in DMEM medium containing 10% FBS and
1× penicillin/streptomycin until reaching 90% conﬂuency and then
were split 1:4. The human ESC-lines H1 and H9 (WiCell Research Insti-
tute, Madison, WI, USA) and iPSCs generated from NBS and HFF1 cells
were cultured on mitomycin-C-inactivated mouse embryonic ﬁbro-
blasts (MEFs). Further details on culturing and passaging human plurip-
otent stem cells (hPSC) can be accessed from Prigione et al. (2010).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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For retroviral reprogramming we used Phoenix amphotropic (PA)
293 cells to produce the virus expressing the four Yamanaka factors
(Takahashi et al., 2007), pMXs-hOCT4, pMXs-hSOX2, pMXs-hKLF4,
pMXs-hC-MYC, or pLIB-GFP (as a titration control) according to our pre-
viously published protocol (Prigione et al., 2014).
NBS ﬁbroblasts were seeded onto 12-well plates at a density of
6 × 104 cells per well (~60% conﬂuence). On the following day, medium
was replaced by DMEM w/o antibiotics, supplemented with 4 mg/ml
polybrene and containing 2.5 transforming units of each factor per cell
(OCT4, SOX2, KLF4, C-MYC, or GFP only). The infection process was re-
peated after 24h and after additional 24h the infected cellswere seeded
onto theMEF/Matrigel coated dishes at a density of 2 × 104 per well of a
6-well plate (~ 1:4) and cultivated with hESC medium. Two to four
weeks later colonies with ES-like morphologies were picked and ex-
panded further.
3.4. Alkaline phosphatase staining and immunocytochemistry
25 days post induction, the staining was performed according to the
manufacturer's instructions of the Stemgent ® Alkaline Phosphatase
Staining Kit.
For immunocytochemistry, plates with cells were rinsed with 0.05%
Tween-20 in PBS (PBS-T) and ﬁxed with 4% paraformaldehyde in PBS
for 10min at RT. Afterwards the cellswere permeabilizedwith 1% Triton
X-100 in PBS for 10 min and blocked by 10% FBS in PBS-T for 45 min at
RT. The primary antibody was diluted in blocking solution and incubat-
ed overnight at 4 °C. The next day, the secondary antibody was usually
diluted 1/300 in blocking solution and applied for 1 h at 4 °C in the
dark. Afterwards the cells were incubated in a staining solution for the
nuclei (DAPI 100 ng/ml in PBS-T) for 10 min. Pictures of ﬂuorescent
staining were taken with a LSM 510 Meta confocal microscope (Zeiss).
For in vitro differentiation, embryoid body (EB) formation of NBS-
iPSCs was induced from mechanically split small colony fragments in
hESC medium lacking FGF-2 supplementation and cultured in “Ultra
Low Attachment Culture Dishes”. They were cultivated for 8 days until
round aggregates were formed, then aggregates were transferred to
gelatin-coated plates (12-well) containing cover slips. The cells were
allowed to differentiate (in hESC medium w/o FGF-2) for 3 (early
markers like SOX17 and BRACHYURY) to 14 days (FOXA2, SMA, NES
and TUJ1) and were ﬁxed and stained according to the immunoﬂuores-
cent protein labeling procedure above.
3.5. Teratoma
The in vivo differentiation experiments (teratoma formation) were
performed by EPO-Berlin GmbH (http://www.epo-berlin.de). Brieﬂy,
per injection, the contents of 3 wells (6-well plate) of near-conﬂuent
grown iPSCs were collected by combined type IV collagenase-treatment
and 0.05% Trypsin/EDTA-treatment. Cells were resuspended in Matrigel
and immediately injected subcutaneously into NOD.Cg-Prkdc scid Il2rg
tm1Wjl/SzJ mice, commonly known as NOD scid gamma (NSG) mice.
Mice bearing teratomas were carefully monitored and sacriﬁced 78 days
after injection. Histological analysis was performed by a pathologist (Dr.
med. Vet. Wolfram Haider, Institut für Tierpathologie, Berlin).
3.6. Karyotype analysis
To analyze the karyotype in NBS ﬁbroblasts and in the generated
iPSC-lines, chromosomal analysis was performed after GTG-banding
by Prof. Dr. Gundula Thiel (Praxis für Humangenetik, Friedrichstraße
147, 10,117 Berlin; http://www.humangenetik-berlin.de). For each
line, between 15 and 20 metaphases were counted and 5 to 8
karyograms analyzed.3.7. Transcriptomics
All array hybridization steps were performed by Claudia Vogelgesang
of the Automation Group (MPI Molecular Genetics). This included
biotin-labeling of cRNA by using 500 ng quality-checked total RNA (per
sample) as input. Chip hybridizations, washing, Cy3-streptavidin staining,
and scanning were performed on an Illumina BeadStation 500 platform
(Illumina) using reagents and protocols supplied by the manufacturer.
cRNA samples were hybridised in duplicates on Illumina human-12
BeadChips (NBS-8, NBS-8-iPSCs, H1, H9 (single), HFF1-iPSCs, BJ-iPSCs).
All basic expressiondata analysiswas carriedout using themanufacturer's
softwareGenomeStudio (Illumina). Rawdatawas background-subtracted
and normalised using the “rank invariant” algorithm.
3.8. Sanger sequencing
The 657del5 mutation in exon 6 of the NBN gene was identiﬁed by
ampliﬁcation of exon 6 by ﬂanking primers (F: CAGATAGTCACTCCGTTT
ACAA, R: ATGAATAGGCCAGTTATCACAG, Varon et al., 1998) and subse-
quent Sanger sequencing by employing the same primers. After PCR,
the products were puriﬁed by QIAamp DNA Mini Kit (Qiagen) according
to the manufacturer's instructions. The sequencing reaction was per-
formed by in-house service (Dr. Bernd Timmermann) of the Max-
Planck Institute for Molecular Genetics, Berlin. Afterwards the raw data
(sequence) was analyzed using “Chromas light 2.01” (McCarthy, 1996).
3.9. Western blot
After separation of 10 μg protein (per lane) in a SDS-PAGE, protein
was transferred to nitrocellulose and the membrane was blocked with
5% milk in PBS-T (blocking solution). After blocking, the membrane
was incubated with primary antibody (NBS1 antibody, rabbit polyclon-
al, Novus Biological, NB100-143) dissolved in blocking solution at 4 °C
overnight. Afterwards the membrane was washed 3 times for 10 min
in PBS-T. Secondary antibody (Anti-rabbit IgG-HRP, derived in goat,
Santa Cruz, sc-2030) dissolved in blocking solutionwas applied by shak-
ing for 1 h at RT. Afterwards the membrane was washed 3 times for
10 min in PBS-T. Luminescence was induced by ECL Plus Western blot-
ting Detection Reagents and captured on BioMAX XAR ﬁlm.
4. Veriﬁcation and authentication
The ﬁbroblasts used for reprogrammingwere derived from a patient
with conﬁrmed NBS (Charité Berlin). A heterozygous 657del5mutation
in the patientwas detected by Sanger sequencing (Fig. 2a). The 657del5
mutation leads to truncation of the wild-type protein (p95 NBN). The
wild-type version of the NIBRIN protein was detected by Western blot
in control samples of ﬁbroblasts and hPSCs, but not in NBS ﬁbroblasts
and NBS-iPSCs (Fig. 2a and b). The NBS-iPSCs expressed pluripotency
markers (Fig. 1a and b).
Embroid body-based differentiation and teratoma formation gener-
ated cell types representative of the three germ layers as detected by
immunoﬂuorescence and histological analysis (Fig. 1c and d).
Conﬁrmation of pluripotency in the iPCS-lines (Fig. 1c and d)
employed Pluritest (Müller et. al., 2011).
Karyotype analysis showed a normal karyotype apart from one
derivative chromosome 11 [46,XY,der(11)t(5;11)(q12;q25)] in
vNBS8-iPS-c1 (Fig. 1g). The second clone, vNBS8-iPS-c2, had two ab-
errant karyotypes. One, with trisomy 8 and a derivative chromosome
11 with the frequency of 12 in 15 counted metaphases
[47,XY,+8,der(11)t(5;11)(q12;q25)]. The second one occurred
with a frequency of 3 in 15 counted metaphases and contained an
isochromosome of the long arm of chromosome 1, a derivative chromo-
some 4with additionalmaterial of unknown origin and different banding
pattern, a deletion in 13q and additional material of unknown origin at
17p (47,XY + i(1)(q10),add(4)(p15),del(13)(q13),add(17)(p11)).
Fig. 1. Characterisation of NBS-iPSCs. a) Representative alkaline phosphatase staining (in pink) of vNBS8-iPSC-colonies in one well (6-well-plate, left) and at 10× magniﬁcation (right);
b) Immunoﬂuorescence based detection of pluripotency markers in NBS-iPSCs; c) Immuno-ﬂuorescent detection of differentiation markers after embryoid body differentiation of
vNBS8-iPSCs; d) Teratoma formation in immune-deﬁcient mice after transplantation of vNBS8-iPSCs, containing tissues of all three germ layers; e–f) Transcriptomics-based analysis of
ﬁbroblasts (HFF1, BJ, NBS8_ﬁb), hESCs (H1, H9) and reprogrammed cells (*iPS*) to determine iPSC quality by calculation of the novelty score (e), which describes the similarity of the
samples with samples from the database and should be low in order to show high similarity and by calculation of pluripotency score (f), which gives an indication if a sample contains
a pluripotent signature, the higher the value, the more likely the stemness. g) Karyograms of NBS8 cells before (NBS-8) and after reprogramming (NBS-8-iPSCs) and one control iPSC-
line (HFF1-iPSCs), in red boxes the chromosomes affected by aberrations.
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